Table 3. Meta-analysis of the association between LMR and clinicopathological features of HCC.

Characteristics	No. of studies	No. of patients	OR (95% CI)	p	Heterogeneity
					I2 (%)	Ph
Gender (male vs. female)	3	913	1.16 (0.64–2.09)	0.62	54	0.11
AFP (>400 ng/mL vs. <400 ng/mL)	2	660	1.61 (0.81–3.20)	0.17	73	0.05
Liver cirrhosis (yes vs. no)	3	913	1.66 (0.97–2.83)	0.06	52	0.12
Differentiation (low vs. moderate/high)	3	913	1.04 (0.74–1.46)	0.82	0	0.88
Tumor number (multiple vs. single)	2	660	0.96 (0.62–1.50)	0.87	0	0.61
Tumor size (>5 cm vs. <5 cm)	3	913	1.36 (0.79–2.35)	0.27	69	0.04
TNM stage (III-IV vs. I-II)	2	703	1.78 (1.19–2.68)	0.005	33	0.29
BCLC stage (B/C vs. A)	2	703	1.70 (1.21–2.39)	0.002	0	0.38
Vascular invasion (pos vs. neg)	2	660	1.47 (0.48–4.49)	0.50	84	0.01